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The development of novel nanomaterials with unique
physico-chemical properties is increasing at a rapid rate,
with potential applications across a broad range of
manufacturing industries and consumer products. Nano-
material safety is therefore becoming an increasingly
contentious issue that has intensified over the past 4 years,
and in response, a steady stream of studies focusing on
nanotoxicology are emerging. However, it is becoming
increasingly evident that nanomaterials cannot be treated
in the same manner as chemical compounds with regards
to their safety assessment, as their unique physico-chemical
properties are also responsible for unexpected interactions
with experimental components that generate misleading
data-sets. In this report, we focus on nanomaterial inter-
actions with colorimetric and fluorometric dyes, compo-
nents of cell culture growth medium and genotoxicity assay
components, and the resultant consequences on test systems
are demonstrated. Thus, highlighting some of the potential
confounding factors that need to be considered in order to
ensure that in vitro genotoxicity assays report true biological
impacts in response to nanomaterial exposure.
Introduction
Nanogenotoxicology is a sub-discipline that has recently
emerged as a result of the dramatic expansion of the
nanotechnology industry, which is continuously developing
new nanomaterials at a rapid rate. Although we have been
exposed to particles on the nanoscale for centuries through
environmental sources such as volcanoes, viruses, dust storms
and, more recently, increasing air pollution, engineered nano-
materials represent a new and largely undefined risk (1–3).
Over the last 4 years, the health and environmental safety of
nanomaterials has therefore drawn increasing attention with the
first report highlighting the distinct lack of information on
human health and environmental impacts of engineered
nanomaterials published in 2004 by the Royal Society and
Royal Academy of Engineering (4). Several other governmen-
tal reports have emerged since (5–7), but in this time, the safety
considerations have certainly not parallelled the growth of the
material development side of the nanotechnology industry. A
steady stream of publications are now starting to emerge that
demonstrate that there is substance behind the concerns, as they
report that many nanomaterials do indeed induce cytotoxicity,
oxidative stress and inflammatory responses, but there are
many uncertainties and conflicts in the literature (8–11). Given
the expected consumer, occupational and clinical exposure
scenarios predicted in the future, it is therefore imperative that
we understand and thereafter minimize any safety hazards
associated with nanomaterials, not only to protect human
health and the environment but also to avoid damaging the
nanotechnology industry in the long term.
Nanomaterials are defined as substances with at least one
dimension,100 nm. They come in a myriad of different forms
with current estimates suggesting .1900 different types of
nanomaterials have been designed and fabricated, each of
which with distinct physico-chemical features (Nanowerk
Nanomaterial Database). They range in their dimensions,
shape (spheres, rods, cages, fibres, tubes) and composition
(individual metals, metal oxides, binary metals or more
complex combinations), with further intricacies introduced
through the vast array of surface modifications (e.g. dextran,
polyethylene glycol, DNA, amines, carboxyl groups, proteins)
to suit specific applications. Consequently, nanomaterials are
promising to revolutionize our lifestyles by improving a wide
range of industrial, consumer and medical health care products.
Some nanomaterials such as carbon nanotubes have very high
tensile strength but are light and therefore pose many
advantages over the use of more traditional metals in the
automotive and aerospace industries (12). Due to their large
surface area, nanomaterials often have unusual catalytic
properties that have demonstrated great promise in improving
propellant and fuel catalysts, automotive catalytic converters
and also in environmental remediation where they will readily
react with pollutants to detoxify them (13,14). Other
applications include nanoelectronics (enhanced monitor reso-
lution, high-energy batteries), but more direct human contact is
likely to come from the personal care and medical health care
products that are being developed. Titanium dioxide and zinc
oxide nanoparticles can be found in suncream, while anti-
ageing creams and cosmetics such as lipstick are now also
being manufactured with nanoparticles as a component. Nano-
materials are not currently being used in the clinic, but recent
studies have found that they have the potential to be applied to
the development of novel tissue scaffolds, as nanomedicines,
intelligent drug delivery systems able to target specific diseased
cells and in improved non-invasive techniques for enhancing
medical imaging capabilities (15,16). One material in particular
that is already starting to leave an impression within the clinical
arena is ultrafine superparamagnetic iron oxide nanoparticles
(USPION). These nanoparticles have been found to sub-
stantially increase the contrast of magnetic resonance imaging,
but can also be used as targeted drug delivery vehicles (by
localizing magnetic particles carrying drugs to specific sites
using magnetic fields) and in the destruction of tumour tissue
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through magnetic tumour ablation, known as hyperthermia
(17).
Clearly, if the future applications of nanomaterials are
realized, there is likely to be extensive occupational, consumer
and clinical exposure. Primary routes of uptake into the body
will be via the respiratory tract, gastrointestinal tract or through
the skin, but injection or implantation of novel nanomedicines,
tissue replacements or imaging agents represent an alternative
entry route into the body. Thus, there is clearly a need for an
understanding of the toxicological implications associated with
exposure to engineered nanomaterials, but a complication that
sets them aside from more conventional chemical or pharma-
ceutical safety testing is the necessity for complete physico-
chemical characterization alongside their genotoxicological
assessment (18). This is an essential consideration as the
specific physico-chemical parameters of nanomaterials are
responsible for creating their novel characteristics that enable
the above described applications plus many more, but these
same features may also govern unexpected biological inter-
actions.
An obstacle that is now becoming increasingly evident is
that traditional genotoxicological assays have been standard-
ized and optimized for chemical compounds and we cannot
assume that nanomaterials can be tested in the same way. Due
to their size, nanomaterials have large surface areas as the
particle number per unit weight is substantially higher than if
they were micron sized. This characteristic provides them with
particularly high reactivity because surface atoms usually have
unsatisfied high-energy bonds that will readily interact with
other molecules to become stabilized (19). Thus, nanomaterials
are able to readily adsorb a wide variety of organic molecules
and macromolecules on to their surface, which may influence
the results of in vitro experiments in particular if adequate
measures to assess these interactions have not been applied.
Given the reactivity of nanomaterials, assay compatibility is
a very important consideration, which if not given enough
credence, can have a dramatic impact on the validity of
resultant data-sets and will therefore be the focus of this report.
We will review and demonstrate some of the hurdles that may
be encountered with in vitro testing systems in the form of
nanomaterial interactions with experimental components,
drawing attention to potential sources of error that would
unwittingly generate misleading results. Many of these factors
are only just coming to light, and thus are likely to account for
some of the inconsistencies in the current literature, which
contribute to the difficulty in reaching firm conclusions on the
safety of nanomaterials. Accounting for such confounding
factors within the experimental system when initiating nano-
genotoxicology investigations will therefore improve the
quality of in vitro assays, providing more reliable and
reproducible data-sets.
Colorimetric and fluorometric dyes
Central components in a range of assays that compliment
genotoxicity testing are colorimetric and fluorescence dyes that
are capable of providing additional information such as
quantification of cell viability or indicators for mechanisms
of action. In many of these test systems, accurate and
reproducible quantitation of colorimetric or fluorescence
absorption and emission variations at specific light wave-
lengths are critical. Thus, if the test substance has the capacity
to alter the optical properties of these dyes, the resultant data-
sets will be inaccurate and could subsequently lead to flawed
interpretations that may have a heavy influence upon safety
assessment exercises.
Colorimetric and fluorometric dyes are proving to be
problematic when incorporated into assays along with nano-
materials as there is increasing evidence that certain nano-
materials interact with these agents leading to false absorbance
results. For example, several studies have found that carbon-
based nanomaterials and carbon nanotubes interact with both
fluorometric and colorimetric dyes in a range of cell viability
assays including the 3-(4,5-dimethylthiazole-2-yl)-2,5-biphe-
nyl tetrazolium bromide (MTT), neutral red, alamar blue,
2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-
tetrazolium, monosodium salt (WST-1) and Coomassie blue
assays, leading to unreliable results (20–26). Furthermore,
carbon nanotubes have been found to interact with organic
dyes and the pH indicator (phenol red) often incorporated in
tissue culture growth medium, altering their absorption or
fluorescence spectra (27–30). The precise mechanisms in-
volved in many of these interferences are not well understood,
but carbaceous material is notorious for its ability to adsorb
organic molecules and macromolecules from aqueous sol-
utions through van der Waals forces. It is therefore likely that
this effect is exacerbated when they are reduced to the
nanoscale because of their increased surface area. Carbon
nanomaterials therefore have the capacity to adsorb dyes onto
their surface, which would subsequently quench or alter their
fluorescence or absorbance properties and this has indeed
been observed in a number of studies (21,22,25,26). However,
this scenario is simplistic and factors such as surface
chemistry, fabrication process or the types of surfactants used
to disperse the nanomaterials also appear to play a role in
governing the interactions and degree of interference with
colorimetric and fluorometric dyes (20).
These observations are not only limited to carbon-containing
nanomaterials. Silver nanoparticles have been found to cause
spectral changes when they interact with fluorescent dyes,
specifically altering emission intensity and in some cases
quenching them altogether (31). We have also found in our
studies that dextran-coated USPION interfere with the 3-
(4,5-dimethylthiazole-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium (MTS) cell viability assay. This
test is based on the reduction of the MTS salt to a soluble
formazan product by cellular metabolism, the absorbance of
which is measured at 490 nm and thus is directly proportional
to the number of live cells. It is a simple method for the
sensitive measurement of cell viability and thus has been
adopted in a number of studies for the assessment of
cytotoxicity induced by zinc oxide, titanium dioxide and iron
oxide nanoparticles (32,33). However, we have found that
when USPION are mixed with the necessary components of
the MTS assay in a cell-free system, absorbance readings at
490 nm are dramatically increased (Figure 1), thus compro-
mising its ability and sensitivity to accurately measure cell
viability in response to USPION exposure. Hence, preliminary
experiments on all colorimetric assays are necessary to identify
any artifactual sources and in some cases there may be a need
to assess cytotoxicity with more than one test system or avoid
assays using coloured or fluorescent reagents in favour of direct
cell counting.
In addition to cell viability assays, fluorescence-based dyes
are key reporters for oxidative stress, which is particularly
problematic as this is one of the primary mechanisms
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associated with negative cellular responses to nanomaterials.
Of the wide ranging and diverse methodologies and techniques
available for the detection and measurement of oxidative stress,
most assays fall into one of three main categories: (i)
quantitation of oxidative species, (ii) determination of the
degree of oxidative damage to proteins, DNA or lipids and (iii)
assays that quantify levels of antioxidants. The only direct way
of measuring specific reactive oxygen species (ROS) is through
electron spin resonance (ESR; also called electron para-
magnetic resonance). Pacurari et al. (34) used this technique
for investigating ROS production induced by human mesothe-
lial cells exposed to single-walled carbon nanotubes (SWCNT),
but there is currently no information on whether or not ESR is
subject to interference by nanomaterials. However, this
technique is not readily available in most laboratories and
thus is not as frequently used for detecting nanoparticle-
induced oxidative stress as other techniques such as those
based upon fluorometric dyes, which are both convenient and
sensitive. An example of a widely used probe for the detection
of oxidative stress is the fluorometric dye 2#,7#-dichlorofluor-
escin-diacetate (DCFH-DA) (35,36). This probe has been used
extensively for quantitating nanomaterial-induced ROS in
a range of cell types, some examples of which include iron
oxide nanoparticles exposed to mesenchymal stem cells and in
HeLa (human cervical carcinoma) cells (37); SWCNT-induced
ROS in HaCaT (human keratinocyte) cells (38); ROS induced
by ultrafine carbon black in the J774 (mouse macrophage) cell
line (39) and by ambient ultrafine particles, cationic poly-
styrene nanospheres, TiO2 and fullerol nanoparticles in RAW
264.7 phagocytic cells (40).
Initiation of the DCFH-DA assay requires the diacetate
portion of the molecule to be cleaved. In acellular systems, this
can be achieved by chemical means (e.g. using sodium
hydroxide) or through media-induced cleavage (41). However,
this dye is most commonly used to detect intracellular ROS,
as the hydrophobic DCFH-DA molecule readily penetrates
the cell membrane, and then the diacetate portion is enzy-
matically cleaved by ubiquitous intracellular esterases. The
non-fluorescent DCFH is subsequently oxidized by ROS to its
highly fluorescent product 2#,7#-dichlorofluorescein (DCF)
(42,43). Excitation of the DCF molecule at 485 nm emits green
fluorescence at levels proportional to the amount of ROS
present, which can be detected at 520 nm by fluorescence
microplate readers, flow cytometry or confocal microscopy.
However, DCFH has an unstable nature. It is slowly oxidized
in air to DCF and is also prone to photo-oxidation by the laser
light utilized for fluorescence microscopy. Thus, detection of
intracellular fluorescent DCF is prone to false-positive results
(35,44).
Another consideration when using DCFH-DA for quantify-
ing nanomaterial induced oxidative stress, as with all
fluorometric and colorimetric dyes is the possibility of their
direct interaction with the probe, which can also lead to
misguided interpretations. Indeed, we have found that in a cell-
free system, dextran-coated iron oxide nanoparticles were able
to interfere with the fluorescence emission of DCFH, the
degree of which varied according to the concentration of
the dye and the oxidation state of the nanoparticles (Figure 2).
The interference was more pronounced with Fe3O4 than Fe2O3
nanoparticles, the former of which caused a significant dose-
dependent decrease in fluorescence emission at both concen-
trations of dye tested, suggesting that the nanoparticles may be
quenching the fluorescence response, possibly through adsorp-
tion onto their surface. In contrast, where interference was
observed with Fe2O3, at very low doses, the fluorescence signal
was slightly decreased and then increased in a dose-dependent
manner after 0.1 lg/ml. The mechanism underlying this pattern
of interference with the fluorescence response is currently
unknown. However, a possibility is that Fe2O3 is able to
quench fluorescence response at low concentrations (as Fe3O4
does), but it might have a higher oxidative potential than Fe3O4
Fig. 1. Consequence of USPION in varying concentrations of serum, on the
absorbance at 490 nm of the Cell Titre Aqueous Non-Radioactive MTS cell
viability assay (Promega, Southampton, UK) performed according to the
manufacturers’ instructions, but in a cell-free system.
Fig. 2. Effect of dextran-coated USPION on fluorescence emission by DCFH-
DA in a cell-free system: (A) Fe2O3 nanoparticles and (B) Fe3O4 nanoparticles.
Two DCFH-DA concentrations were investigated, according to the range
suggested by the manufacturer (Molecular Probes, Invitrogen, Paisley, UK).
The diacetate portion of DCFH-DA was cleaved off using NaOH and the
resulting DCFH was neutralized with phosphate buffer (pH 7.4) prior to
incubation with the test nanoparticles. Fluorescence emission was then
recorded at 520 nm. All experiments were performed in triplicate, with error
bars representing standard deviation (*P , 0.05; one-way analysis of variance
with Dunnett’s post hoc test used to compare absorbance of USPION dosed
samples to the control where water was used in place of the nanoparticles).
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nanoparticles, such that at higher concentrations, their
oxidative ability outweighs their fluorescence quenching
potential, resulting in an overall increase in fluorescence
response. Thus, with regards to DCFH-DA, potential inter-
actions with nanoparticles need to be considered if the
investigators wish to reliably use the assays in a quantitative
manner.
DCFH-DA detects a wide range of oxidative species as DCFH
can be oxidized by RO2
 , RO, OH, HOCl and ONOO (but not
O2
 and H2O2), hence its popularity. However, in some cases, an
investigator may wish to detect a specific ROS species. There are
therefore a number of alternative fluorescence probes for the
detection of ROS and an example that has been specifically used
to assess oxidative stress induced by SWNCT in RAW 264.7
macrophages is dihydroethidine (DHE) (45). This assay is
capable of detecting superoxide, which oxidizes DHE to the
fluorescent product 2-hydroxyethidium that intercalates into
nuclear DNA, to emit strong fluorescence (46). However, as yet,
there is no evidence to indicate how reliable these alternative
dyes are when incorporated into experimental systems contain-
ing nanomaterials.
For assays that utilize colorimetric or fluorometric dyes, it is
therefore critical to consider and control for the possibility that
the test nanomaterial may react with the detection method. As
we have seen, even subtle differences in oxidation state can
have very different impacts on resultant data-sets. Thus, such
interference will need to be assessed on a nanomaterial-by-
nanomaterial basis until we fully understand the physico-
chemical properties underlying these interactions.
In vitro culture medium components
Unlike the dyes mentioned in the previous section, cell culture
underpins all in vitro genotoxicity tests and thus cannot be
avoided. Consequently, interactions between nanomaterials
and growth medium components will almost certainly impact
on any subsequent genotoxicity test results. Such potential
interactions therefore need to be identified, and where possible
avoided or controlled for to ensure the reliability of subsequent
data-sets.
Culture medium contains an array of growth factors, proteins
and nutrients necessary to support cell growth, but biomole-
cules are readily adsorbed onto the surface of nanomaterials
forming what is now referred to as a nanomaterial–protein
corona (47). The density and composition of this adsorbed
protein layer are likely to be dependent upon the make-up
of the aqueous or physiological environment, in combination
with the physico-chemical features of the nanomaterial itself,
thus the corona is likely to consist of a dynamic and complex
mixture of proteins. This protein coat would be directly in
contact with cells during dosing regimes, as it essentially masks
the nanomaterial. Hence, recent evidence indicates that the
protein corona is responsible for governing uptake and
intracellular location, thereby modulating cellular responses
to nanomaterial exposure (47,48).
In support of the importance of considering the protein
corona, a number of reports in the literature have indicated that
serum content in cell culture medium can influence nano-
material uptake into cells, but it is both cell type and
nanomaterial dependent. For example, serum is responsible
for decreasing the cellular uptake of silica-coated nanoparticles
and anionic maghemite nanoparticles in HeLa cells, but uptake
of the latter nanoparticles by macrophages is promoted by
serum (49,50). We have observed in our own studies that
serum negates the uptake of dextran-coated USPION by human
lymphoblastoid B-cells (MCL-5) as illustrated in Figure 3. This
negative effect of serum on nanoparticle uptake may be the
result of an increased hydrodynamic diameter or altered
electrostatic charges following adsorption of the serum proteins
onto the surface of the nanomaterials. This would reduce the
ability of these nanomaterials to enter cells by endocytosis or
diffusion, while making them a more prominent target for
phagocytosis by macrophages. Serum interactions with nano-
materials therefore have the potential to weigh heavily on the
resultant biological impact of exposure to these substances
where genotoxicity assays are concerned. For example, the
presence of 10% serum in the culture medium during exposure
of human lung epithelial cells to SWCNT substantially reduces
the level of micronuclei (corresponding to chromosomal
damage) induced (Figure 4).
In contrast, amorphous silica nanoparticles are more toxic to
RAW 264.7 macrophage cells in the presence of serum than
when dispersed using the surfactant Pluronic F127, possibly as
the protein–nanoparticle interactions govern cellular uptake
(54). However, in this same study, no such effect was seen with
SWCNT, highlighting the dependence upon the physico-
chemical characteristics of the nanomaterial itself in influenc-
ing the adsorption of proteins onto their surface and the
resultant cellular consequences.
A conflicting observation is that serum acts as a surfactant to
disperse nanomaterials, which are inherently hydrophobic and
this has been reported in numerous studies with a range of
nanomaterials including SWCNT, metals and metal oxide
nanoparticles (27,55–59). Indeed, we have observed ourselves
such an effect with dextran-coated USPION, where the
hydrodynamic diameter of the agglomerated nanoparticles is
lower in medium containing 10% serum as compared to 1%
serum (Figure 5), which could be attributed to destabilization
of the aggregates by the serum proteins. However, with
increasing concentration, the aggregate size becomes larger and
the degree of dispersal caused by 1% versus 10% serum
becomes less pronounced, which has also been noted with
several other nanoparticles (56,57). Hence, size measurements
at a single concentration does not provide sufficient in-
formation on the experimental dynamics of nanomaterial
agglomeration. Given that size distribution and agglomeration
will impact the capacity for cellular uptake and subsequently
their genotoxic potential, they should be assessed over a range
of appropriate doses under the experimental conditions utilized.
Thus, in nanogenotoxicity studies, it is becoming increasingly
apparent that physico-chemical features must be characterized
under the experimental setting so that definitive associations
between these parameters and any biological responses
observed may be identified. There are, however, difficulties
in monitoring nanomaterial behaviour when dispersed in
physiological solutions as the latter often contain particulate
and charged materials that will mask the true size distribution
and charge measurements of the nanomaterials themselves.
Agglomeration can also be temperature dependent and so
measurements should be made at 37C, which requires
temperature-controlled equipment. Additionally, many of the
techniques currently available to assess surface area, morphol-
ogy and composition are reliant on dry samples and so are
difficult to apply to nanomaterials in solution. Novel or adapted
technologies therefore need to be developed to enable
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physico-chemical characterization of nanomaterials under these
complex conditions.
Furthermore, there is evidence that the culture medium
components themselves may be involved in cellular toxicity
through nanomaterial interactions. For example, in addition to
serum, SWCNT have been found to interact with pH indicators
and riboflavin (vitamin B2) in growth medium, reducing the
effective concentrations of nutrients in the cultures and thereby
facilitating unfavourable growth conditions which could extend
Fig. 3. Consequence of serum concentration in culture medium on cellular uptake of dextran-coated USPION. (A) Iron content in MCL-5 cells after exposure to 100
lg/ml USPION in the presence of either 1 or 10% serum, as measured by the ferrozine assay (51); *P , 0.05; Student’s t-test was used to compare the differences
between the iron content in cells dosed with USPION in the presence of 1% versus 10% serum. Experiments were performed in duplicate and error bars represent
the standard deviation, (B) Images of Prussian blue-stained cells after USPION exposure in 10% serum and (C) in 1% serum (staining was as described in ref. (52)
blue staining corresponds to iron, while the cells are stained pink by nuclear fast red), (D) Transmission electron microscopy image of dextran-coated USPION
internalized into MCL-5 cells after a 100 lg/ml treatment in the presence of 1% serum for three cell cycles—white circle corresponds to region imaged at higher
resolution in inset, where black spots representing the nanoparticles can be clearly seen.
Fig. 4. Comparison of the effects of serum on the induction of micronuclei by
SWCNT using the CBMN assay. BEAS-2B lung epithelial cells were treated
with SWCNT that were dispersed in tissue culture media by sonication for 1 h
at 4C immediately before application to the cells. The experimental and
analysis methodologies used were as described in ref. (53); however, BEAS-
2B cells were sequentially exposed to the SWCNT for 48 h followed by
cytochalasin B treatment. All doses were performed in duplicate.
Fig. 5. Average size of dextran-coated USPION agglomerates diluted in
complete growth medium containing either 1 or 10% serum at a range of
concentrations, as measured by a high-performance particle sizer (Malvern
Instruments, Worcestershire, UK). Numbers above the bars represent the
average diameter of the agglomerates (nanometre) after eight measurements,
while error bars represent the standard deviation.
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to an indirect toxic effect (60). This study also highlighted
that the level of interaction observed was dependent upon the
fabrication methodology used to synthesize the SWCNT with
high-pressure carbon monoxide conversion nanotubes demon-
strating increased interaction with medium components as
compared to nanotubes generated by the arc discharge method.
Thus, the effects of serum and culture media components
clearly need to be established on an individual nanomaterial
basis prior to toxicological evaluation. Most reports to date
have focused on serum, with it acting as a dispersant in some
cases, reducing the overall size of the nanomaterial exposed to
the cells and hence facilitating cellular internalization, possibly
via receptor-mediated endocytosis or simple diffusion across
the membrane. While in other cases, the serum proteins
adsorbed onto the surface of the nanomaterial actually hinder
their uptake in certain cell types. It is therefore becoming
apparent that to further understand the nature of cellular
responses to nanomaterials, characterization of the dynamic
protein–nanomaterial interactions and the resultant adsorbed
corona that forms under experimental conditions is an
important challenge to be addressed. However, the consequent
impact is also dependent upon the chemical properties of the
nanomaterial surface and thus re-enforces the requirement for
thorough physico-chemical characterization in parallel with
adequate controls to assess potential confounding factors
within in vitro safety testing studies.
Genotoxicity assay components
Most genotoxicity assays rely on a large number of intrinsic
reagents essential to the testing methods’ ability to report on
a specific cellular response following exposure to an exogenous
agent. Due to the inherent reactivity of nanomaterials, this
proves to be a potential problem as the test materials may
themselves interact with key assay components, rendering them
unfit for their given purpose. An example we will address here
is focused on the cytokinesis-blocked micronucleus (CBMN)
assay.
The micronucleus assay is a sensitive quantitative measure
of the degree of gross chromosomal damage induced by a test
agent, which can subsequently be classified as clastogenic
events (chromosomal fragmentation) or aneugenic damage
(changes in chromosome copy number). However, this assay
can be performed using a number of slightly differing
methodologies as illustrated in Figure 6. The schematics in
Figure 6A and B are referred to as the CBMN assay and rely on
the use of cytochalasin B to inhibit cytokinesis, generating
binucleated cells in which the micronucleus frequency is
scored. Alternatively, the mononuclear micronucleus assay can
be used, which does not require cytochalasin B. Often, the
CBMN assay is the preferred method as it limits the scoring of
cells to only those that have undergone mitosis in the presence
of the test compound. However, this is potentially a problem
with regards to the study of nanomaterials because cytochalasin
B also inhibits endocytosis, which is an important cell uptake
mechanism favoured by some nanomaterials. Indeed, we have
found that the specific micronucleus assay methodology
utilized is a very important consideration for ultrafine nano-
particles, where endocytosis plays a key role in facilitating their
cellular internalization. As illustrated in Figure 7, a significant
dose-dependent increase in micronuclei when MCL-5 cells are
exposed to dextran-coated USPION is only observed when the
CBMN assay is performed with sequential treatment with the
nanoparticles, followed by cytochalasin B (i.e. as illustrated in
Figure 6A). When the USPION and cytochalasin B are co-
exposed, no increase in micronucleus frequency is induced
over a wide dose range, suggesting that the nanoparticles are
not becoming internalized due to the inhibition of endocytosis.
Interestingly, the mononuclear micronucleus assay also failed
to detect any increase in genotoxicity, but this is likely to be
due to the sensitivity of the assay, in that double the number
of cells need to be scored to observe the same level of
micronuclei. In the CBMN assay, micronuclei are scored in
cells that are prevented from completing division. Hence, it
follows that when one micronucleus is scored in one binucleate
cell, if that cell were allowed to continue to divide, the
micronuclei would only be located in one of the subsequent
daughter cells. Thus, only one micronucleus would be scored
out of two mononuclear cells (61).
SWCNT have very different physico-chemical features as
compared to ultrafine nanoparticles, so we also assessed the
sensitivity of all three version of the micronucleus assay
methodology to determine the most sensitive for this type of
nanomaterial. The SWCNT assessed were synthesized by the
HiPCO method, had lengths of 400–800 nm, a 1- to 2-nm
diameter, 98% purity and a surface area of 585 m2/g. As can be
seen in Figure 8, there were differences in the frequency of
micronuclei reported by each of the three assays. When
Fig. 6. Micronucleus assay methodologies. (A) Cytokinesis-blocked method, with sequential exposure to the test agent, followed by cytochalasin B treatment, (B)
cytokinesis-blocked method with simultaneous exposure to the test agent and cytochalasin B treatment and (C) mononuclear micronucleus assay.
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considering the CBMN assay with simultaneous exposure of
cytochalasin B with 50 or 100 lg/ml SWCNT, significant
increases in micronucleus frequency were observed. This
suggests that endocytosis is not the only means for SWCNT
uptake leading to DNA damage, as micronuclei were observed
despite the co-incubation of both SWCNT and cytochalasin B.
Nonetheless, these alternative mechanisms of uptake appear to
reach saturation as the same frequency of micronuclei was
present at the two highest doses, while with the other two
versions of the assay a dose-dependent increase was observed.
Endocytosis may therefore be at least partially involved,
accounting for the continuing increase in DNA damage with
dose in both the mononuclear and the sequential CBMN
assays. Indeed, when the shape of the micronucleus frequency
curve is considered, it is very similar for both the mononuclear
and the sequential CBMN assays, providing firm evidence for
the significant dose-dependent increase in chromosomal
damage following exposure to these SWCNT. However, the
frequency of micronuclei observed in the mononuclear assay is
approximately half that detected by the sequential CBMN
assay, as expected due to the nature of the scoring (as
mentioned above).
Both dextran-coated UPSION and SWCNT therefore
demonstrate genotoxicity at non-cytotoxic doses, but these
examples clearly demonstrate that careful consideration is
required when utilizing traditional methodologies to assess the
genotoxicity of nanomaterials.
In vitro exposure regime considerations
An important parameter in any in vitro genotoxicological assay
is the duration of exposure, which typically does not exceed 24
h for chemical compounds due to their capacity to diffuse into
cells and the length of their half-lives. However, the uptake
and movement of nanomaterials through cells are likely to
be slower than chemical diffusion and thus longer exposure
periods may be necessary for effects such as genotoxicity
to develop. To date, there are very few studies that have
considered treatment times .24 h, with exception of an
investigation on cobalt nanoparticles where uptake at 48 h was
double that seen at 24 h (62) and in support, we have also seen
the same increased uptake with time for dextran-coated
USPION (data not shown).
In relation to exposure time, the long-term fate of nano-
materials once inside cells is another currently unknown factor.
This carries significant importance because the nanomaterial
itself may not represent a genotoxic risk, but over time it might
break down or corrode within cells resulting in the release of
free metal ions that, depending upon the element, could be
carcinogenic. There is limited evidence to support this in the
literature to date, but zinc oxide nanowires have been found to
break down and release zinc ions in horse serum (63), while
Fig. 7. Comparison of micronucleus assay data generated following exposure of MCL-5 human lymphoblastoid B-cells to dextran-coated USPION for 24 h in the
presence of reduced (1%) serum. All experiments were performed in duplicate, with scoring as described in ref. (53). (A) CBMN assay with simultaneous exposure
of USPION and cytochalasin B, (B) CBMN assay with sequential exposure to USPION followed by cytochalasin B and (C) mononuclear micronucleus assay (*P,
0.05; Fisher’s exact test used to compare frequency of micronuclei in treated samples to the control where water was used in place of the diluted USPION exposure).
Fig. 8. Comparison of micronucleus assay data generated following exposure
of BEAS-2B lung epithelial cells to SWCNT for 48 h in the presence of
reduced (2%) serum. Immediately before application to the cells, SWCNT
were dispersed in tissue culture media by sonication for 1 h at 4C. All
experiments were performed in duplicate, with scoring as described in ref.
(53). CBMN Sim—CBMN assay with simultaneous exposure of SWCNT and
cytochalasin B, CBMN Seq—CBMN assay with sequential exposure to
SWCNT followed by cytochalasin B and Mn Mono—mononuclear
micronucleus assay.
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another study has attributed the pro-inflammatory effects of
cobalt nanoparticles on endothelial cells, to the release of Co2þ
ions (64). Unfortunately, as most studies do not go .24-h
exposure periods, or consider the state of the nanomaterials
within the cells over extended periods of time as compared to
their original characteristics, this data are currently lacking and
further research is required to answer some of these questions.
Another consideration is dosimetry, which concerns quan-
tifying dose in terms of the true quantity of nanomaterial
internalized into a population of cells. Due to the inherent
hydrophobicity of many nanomaterials, they often have
a tendency to agglomerate in aqueous environments, which
will largely negate the uptake of most of the administered dose
into many non-phagocytic cell types, with only those particles
that remain dispersed or as very small agglomerates becoming
internalized. Yet, the degree of agglomeration is likely to vary
with time during the exposure period due to the mechanics
associated with alterations in surface chemistry of the nano-
materials. Furthermore, large agglomerates may sediment out
of solution due to gravitational settling, the rate of which will
vary according to their size, and thus, the overall exposure to
adherent cell lines versus suspension cells could be very
different. The dynamic evolution of nanoparticle dose in situ or
‘particokinetics’ will clearly impact cellular outcomes and
needs to be considered to develop a detailed understanding of
the factors that govern the genotoxic potential of engineered
nanomaterials (65). However, the practical solutions to address
these issues are currently lacking and will likely require the
development of novel analysis methodologies as existing
technology is unable to accommodate such applications.
Conclusions
It is becoming increasingly evident that nanomaterials cannot
be treated in the same manner as chemical compounds with
regards to their safety assessment as their unique physico-
chemical properties introduce an additional level of complexity.
Until we have a comprehensive understanding of the mechanics
underlying biological responses to nanomaterial exposure, it is
of vital importance that the physical and chemical properties of
the nanomaterials under study are extensively characterized
and that full consideration is given to potential interactions
with inherent experimental components that may give rise to
misleading results. A multidisciplinary approach is therefore
essential to ensure that as much information as possible is
generated about the nanomaterials themselves, in addition to
their dynamic properties under experimental conditions. The
provision of this information together with well-validated (and
where necessary adapted) test systems will be essential to enable
the scientific community to make informed decisions upon the
factors that govern the biological impact of exposure to
nanomaterials and thus ultimately their safety.
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